🇺🇸 CAFFEIC ACID in United States

52 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Platelet Count Decreased — 14 reports (26.92%)
  2. Anaemia — 7 reports (13.46%)
  3. Myelosuppression — 7 reports (13.46%)
  4. Gastrointestinal Haemorrhage — 4 reports (7.69%)
  5. Neutrophil Count Decreased — 4 reports (7.69%)
  6. Pneumonia — 4 reports (7.69%)
  7. White Blood Cell Count Decreased — 4 reports (7.69%)
  8. Cholecystitis — 3 reports (5.77%)
  9. Drug-Induced Liver Injury — 3 reports (5.77%)
  10. Bladder Cancer — 2 reports (3.85%)

Source database →

CAFFEIC ACID in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is CAFFEIC ACID approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for CAFFEIC ACID in United States?

Marketing authorisation holder not available in our data.